Novo Nordisk A/S Sponsored ADR Logo

Novo Nordisk A/S Sponsored ADR (NVON)

BMV

Currency in MXN
795.00
+3.77 (+0.48%)

Closed

Aug 24, 2026

Day's Range

791.00
795.96

52 wk Range

637.43
1,140.00

Profile - NVON - Novo Nordisk A/S Sponsored ADR

Profile

Mic Code

XMEX

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

78.38K


Novo Nordisk A/S Sponsored ADR is a global healthcare company focused on discovering, developing, manufacturing, and marketing pharmaceutical products. Novo Nordisk A/S Sponsored ADR serves patients and healthcare providers through two main business segments: Diabetes and Obesity Care, which includes therapies for diabetes, obesity, cardiovascular, and related emerging treatment areas, and Rare Disease, which addresses specialized conditions such as rare blood disorders and endocrine disorders. The company offers a broad portfolio of prescription medicines and treatment solutions used in chronic disease management across major international markets. Novo Nordisk A/S Sponsored ADR plays a significant role in the pharmaceutical industry by providing products that support long-term treatment needs in both primary care and specialty care settings.

Profile Details

Type

American Depositary Receipt

Ceo

Mr. Maziar Mike Doustdar

Address

Novo Alle 1

City

Bagsvaerd

Zip

2880

Country

Denmark

Phone

45 44 44 88 88

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.